Trilostane, an adrenal steroid synthesis inhibitor, is a primary medical management option for canine hyperadrenocorticism (Cushing's disease), typically requiring an induction and titration period guided by ACTH stimulation testing and clinical response.
Why Titration Flexibility Matters
Because trilostane dosing is adjusted incrementally based on monitoring results and patient response, having access to precise intermediate strengths — rather than being limited to commercial capsule sizes — can simplify titration and reduce the number of dose changes needed to reach a stable maintenance level.
Formulation Options
PetScript Pharmacy compounds trilostane into a palatable oral suspension that supports precise, incremental dose adjustments during induction and maintenance phases, as well as chewable formats for long-term compliance.
Supporting Your Monitoring Protocol
Our clinical compounding pharmacists can work with your practice to build custom strengths aligned to your titration schedule and monitoring intervals. Contact PetScript Pharmacy to discuss formulation support for your hyperadrenocorticism caseload.
Choosing a selection results in a full page refresh.
This content is intended for counseling purposes only. This content is informational/educational and is not intended to treat or diagnose any disease or patient. No claims are made as to the safety or efficacy of mentioned preparations. The compounded medications featured in this content have been prescribed and/or administered by prescribers who work with ProLab Pharmacy. You are encouraged to speak with your prescriber as to the appropriate use of any medication. ProLab Pharmacy’s compounded veterinary preparations are not intended for use in food and food-producing animals. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them..
